Pediatric Drugs: More Illness, But Less Research

Kermit Cole

An international team of researchers identified all drug trials registered in between 2006 and 2011 and tracked the resulting publications, finding that although 60% of the disease burden was attributable to children, only 12% of trials were pediatric. This may be, the authors say, a product of pediatric trials’ greater reliance on governmental and nonprofit funding (60%), in contrast to adult trials’ 65% reliance on industry funding.  Results appeared in Pediatrics, online July 23, 2012.

Abstract → Bourgeois, F., Murthy, S., “Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden” Pediatrics, online July 23, 2012 (doi: 10.1542/peds.2012-0139)

Related Item:
How Psych Drug Studies Shortchange Kids

Previous articleHappiness and First-Episode Schizophrenia
Next articlePsychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families 
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]